15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 17 firms covering Cigna Corp, 14 rate it Buy or better, 3 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets are tightly clustered, $302.00 to $400.00, so the covering firms are broadly aligned. The average target of $345.59 sits 15% above the current $301.52. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $7.62 next quarter toward $33.48 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS17 ratings
Strong Buy
Strong Buy00%
Buy1482%
Hold318%
Sell00%
Strong Sell00%
Based on 17 analysts giving stock ratings to Cigna Corp.
As of Jul, 14 of 17 firms rate CI a Buy (3 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
CI EPS & revenue forecast
EPS · NEXT QUARTER
$7.62
Range $7.25 – $7.92 · 22 analysts · -3% YoY
Next period, 22 analysts expect Cigna Corp to earn $7.62 a share (range $7.25 – $7.92), versus $7.83 a year earlier. Full-year consensus is $30.41, growing to $33.48 the year after.
REVENUE · NEXT QUARTER
$71.8B
Range $69.1B – $74.2B · 22 analysts · +3% YoY
Revenue is expected to reach $71.8B (range $69.1B – $74.2B), +3.0% year-over-year. Full-year consensus is $284.5B, rising to $297.1B next year.
Top analysts covering Cigna Corp
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on CI.
#1
DM
David Macdonald
Truist Securities · Rank #67
Buy
$350.00+16.1% to target
Overall win rate
51%
+ Follow
#2
Ben Hendrix
RBC Capital · Rank #117
Buy
$337.00+11.8% to target
Overall win rate
44%
+ Follow
#3
Sarah James
Cantor Fitzgerald
Buy
$340.00+12.8% to target
Coverage
—
+ Follow
#4
Andrew Mok
Barclays
Hold
$304.00+0.8% to target
Coverage
—
+ Follow
#5
LW
Lance Wilkes
Bernstein
Buy
$381.00+26.4% to target
Coverage
—
+ Follow
CI stock forecast FAQ
What is CI's average 12-month price target?+
The 17 analysts with a live target average $345.59 for Cigna Corp over the next 12 months, ranging from a $400.00 high to a $302.00 low.
Is CI stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 17 analyst ratings, 14 are Buy or Strong Buy, 3 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for CI?+
The Street-high target is $400.00 (UBS), and the Street-low is $302.00 (Deutsche Bank). The average of all 17 active targets is $345.59.
How many Wall Street analysts cover CI?+
17 analysts have an active rating on Cigna Corp, and 17 firms carry a live 12-month price target.
Who is the most accurate analyst covering CI?+
Among analysts who currently cover CI, David Macdonald of Truist Securities has the strongest overall Quantellect track record (Rank #67). Their current call is Buy with a $350.00 target.
What is Cigna Corp's projected EPS for next quarter?+
The consensus estimate is $7.62 per share (range $7.25 – $7.92) across 22 analysts. Full-year EPS is projected at $30.41, rising to $33.48 the following year.
How much revenue is Cigna Corp expected to report next quarter?+
Consensus revenue is $71.8B (range $69.1B – $74.2B). Full-year revenue is projected at $284.5B, growing to $297.1B next year.
Have analysts been upgrading or downgrading CI lately?+
As of Jul, 14 of 17 firms rate CI a Buy (3 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their CI calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
